Patricia M. Logan
10Patents
5h-index
18Co-inventors
59Inventor score
Filing activity: Jan 28, 1993 → Mar 7, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5422362A | Method to inhibit restenosis | Human Necessities | 98 | Expired |
| US5360734A | Method for inactivating pathogens in erythrocytes using photoactive compounds and plasma protein reduction | Human Necessities | 85 | Expired |
| US6723338B1 | Compositions and methods for treating lymphoma | Human Necessities | 22 | Expired |
| US5597722A | Method for inactivating pathogens in compositions containing cells and plasma using photoactive compounds and plasma protein reduction | Human Necessities | 20 | Expired |
| US7244450B2 | Compositions and methods for treating lymphoma | Human Necessities | 7 | Expired |
| US7311924B2 | Compositions and methods for treating cancer | Human Necessities | 5 | Expired |
| US7247316B2 | Compositions and methods for treating lymphoma | Human Necessities | 3 | Expired |
| US7887836B2 | Compositions and methods for treating lymphoma | Human Necessities | 2 | Active |
| US7678775B2 | ILK inhibitors for the treatment of renal disease | Human Necessities | 0 | Active |
| US7504228B2 | Integrin linked kinase modulation of monocyte activation | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.